Robert McDowell
2018
In 2018, Robert McDowell earned a total compensation of $2.6M as Chief Scientific Officer at MyoKardia, a 103% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $180,780 |
|---|---|
| Option Awards | $1,592,479 |
| Salary | $387,562 |
| Stock Awards | $400,400 |
| Other | $1,000 |
| Total | $2,562,221 |
McDowell received $1.6M in option awards, accounting for 62% of the total pay in 2018.
McDowell also received $180.8K in non-equity incentive plan, $387.6K in salary, $400.4K in stock awards and $1K in other compensation.
Rankings
In 2018, Robert McDowell's compensation ranked 4,560th out of 14,244 executives tracked by ExecPay. In other words, McDowell earned more than 68.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,560 out of 14,244 | 68th |
Division Manufacturing | 1,711 out of 5,765 | 70th |
Major group Chemicals And Allied Products | 617 out of 2,128 | 71st |
Industry group Drugs | 516 out of 1,817 | 72nd |
Industry Pharmaceutical Preparations | 399 out of 1,391 | 71st |
Source: SEC filing on April 24, 2019.
McDowell's colleagues
We found five more compensation records of executives who worked with Robert McDowell at MyoKardia in 2018.